Interpace Diagnostics Group, Inc. (IDXG) Releases Quarterly Earnings Results

Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) issued its quarterly earnings results on Thursday. The business services provider reported ($0.65) earnings per share for the quarter, MarketWatch Earnings reports. Interpace Diagnostics Group had a negative return on equity of 53.68% and a negative net margin of 37.14%. The company had revenue of $3.86 million for the quarter.

Shares of Interpace Diagnostics Group (IDXG) opened at 0.80 on Friday. The firm’s market capitalization is $7.03 million. Interpace Diagnostics Group has a one year low of $0.07 and a one year high of $14.25. The company’s 50 day moving average price is $0.90 and its 200 day moving average price is $2.08.

WARNING: This piece was first published by Stock Observer and is the property of of Stock Observer. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at

About Interpace Diagnostics Group

Interpace Diagnostics Group, Inc, formerly PDI, Inc, is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management.

Earnings History for Interpace Diagnostics Group (NASDAQ:IDXG)

Receive News & Ratings for Interpace Diagnostics Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interpace Diagnostics Group Inc. and related companies with's FREE daily email newsletter.

Leave a Reply